Vertex Pharmaceuticals has received a “Moderate Buy” consensus from 29 brokerages, with most analysts either holding or ...

In an era of rising complexity, rapid technology shifts, budget pressures, and uninsurable risks, traditional security approaches no longer suffice. Businesses need to understand where they're ...

Analysts remain bullish on Vertex Pharmaceuticals as HC Wainwright reaffirmed its buy rating with a $550 price target.

This was the stock's second consecutive day of gains.

TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” ...

Web Services is working on revamping its artificial intelligence cloud service, Bedrock, in an effort to make it easier for ...

Vertex Rail Technologies opened in Wilmington in 2014 with promises of over 1,300 jobs and a $60 million investment. ... More than many unfunded services With New Hanover property at a premium, ...

Vertex estimates a target market of 150,000 patients after the expected approval in 2028. By 2030, I project Povetacicept to capture 10% of this niche market, which is valued at around $2 billion.

Leading industry experts join the Vertex Chief Strategy Office to shape product innovation and strengthen global compliance strategies for customersKING OF PRUSSIA, Pa., April 10, 2025 (GLOBE NEWSWIRE ...

If so, you might want to own Vertex Pharmaceuticals (VRTX-0.14%) if you believe corporate CFOs are right about a recession coming. Vertex's fortunes were built on the back of its CF franchise.

The FBI has awarded Vertex Aerospace a potential five-year, $100 million contract to provide maintenance support services for the bureau’s fixed- and rotary-wing aircraft.. According to an award ...